Statistics

Total Visits

Views
Denosumab and bone metastasis-free survival in men with castrate-resistant prostate cancer - Subgroup analyses from an international, double-blind, randomized, phase 3 trial6

Select a period of time:

Number of views in the range

Views
Denosumab and bone metastasis-free survival in men with castrate-resistant prostate cancer - Subgroup analyses from an international, double-blind, randomized, phase 3 trial4

Views

Views
November 20231
December 20230
January 20241
February 20240
March 20240
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
 

Top cities views

Views
Ashburn1
Boardman1
Chicago1
Fort Worth1